Lifecare is a leading brand dedicated to developing advanced miniaturized and implantable long-term sensors. With a strong focus on diabetes, Lifecare aims to assist the more than 500 million people worldwide living with the condition. Their innovative technologies, such as Sencell Science NanoBioSensors, provide accurate and reliable measurements for use in medical, professional, and lifestyle-driven point-of-care environments.

Located in Bergen, Norway, Lifecare also conducts extensive research and development projects in Mainz, Germany. Their research units include state-of-the-art laboratories for MEMS & Sensor Research, Sensor Evaluation and Validation. Lifecare's exceptional team, including the CEO Joacim Holter and CSO Andreas Pfützner, brings years of experience in international R&D, diabetes technology, and product development.

Complemented by a distinguished Board of Directors and Scientific Advisory Board, Lifecare continues to pioneer groundbreaking solutions for managing diabetes and improving patient outcomes. As a listed company on Euronext Growth Oslo, Lifecare is committed to transforming the future of diabetes care through their innovative sensor technology